ArticleScientific reports2025
INS2 lineage cell tracking and insulin expression in the related organs of mice.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
We tracked lineage map of the Ins2 cells in mice and insulin expression in migration sites of cells. We studied effect of the Wnt/β-catenin signaling pathway on the migration. We studied insulin secretion status in submandibular gland of mice under hyperglycemia stress. Cre/loxp system was used to observe migration sites and timing of the Ins2-cre lineage cells. Immunohistochemistry and immunofluorescence was used to detecte presence of insulin in the Ins2-cre lineage cells. Knockout mice from E9.5 to adulthood was studied to explore role of the Wnt/β-catenin on the migration. Immunofluorescence and the QRT-PCR (Quantitative Real-time Polymerase Chain Reaction) was used to study insulin secretion in submandibular gland under hyperglycemic conditions. Expression sites of the Ins2-cre gene in adult mice decreased compared with postnatal mice, including the pancreas, tongue, submandibular, and brain. In the migration tissues of ins-cre cells, positive insulin expression was detected in the submandibular acinus, vessel element and pancreatic islets. In comparison to wild-type mice, Wnt/β-catenin signaling knockout mice displayed a slight rise of INS2 expression during the neonatal stage, with a notable increase in adulthood, particularly in areas near the oral cavity. Expression of insulin in submandibular gland of mice increased after 6 h of hyperglycemic stimulation (P < 0.05). Ins2 lineage cells can migrate to multiple organs in mice, where insulin may expressed. Inhibition or knockout of the Wnt/β-catenin signaling pathway may indirectly enhance the migratory capacity of INS2 cells. Submandibular glands may secrete insulin under stress of maintaining organismal homeostasis. Wnt/β-catenin may be the therapeutic target of diabetes. Submandibular glands may be a new target organ of gene therapy for diabetic patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.